Targeting phosphorlyated Akt by PTEN gene therapy in human bladder cancer

Author： Tanaka M. Uemura H. Hirao Y. Grossman B.

Publisher： Elsevier

ISSN： 1569-9056

Source： European Urology Supplements, Vol.2, Iss.1, 2003-02, pp. : 69-69

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Molecular Aspects of Bladder Cancer IV: Gene Therapy of Bladder Cancer

By Ardelt P. Bohle A.

European Urology, Vol. 41, Iss. 4, 2002-04 ,pp. : 372-381

Elsevier

Access to resources Recommend Favorite

Adenovirus-mediated suicide gene therapy for experimental bladder cancer

By Sutton M.A. Berkman S.A. Chen S.-H. Block A. Dang T.D. Kattan M.W. Wheeler T.M. Rowley D.R. Woo S.L.C. Lerner S.P.

Urology, Vol. 49, Iss. 2, 1997-02 ,pp. : 173-180

Elsevier

Access to resources Recommend Favorite

c-erbb-2 gene amplification as a prognostic marker in human bladder cancer

By Miyamoto H. Kubota Y. Noguchi S. Takase K. Matsuzaki J. Moriyama M. Takebayashi S. Kitamura H. Hosaka M.

Urology, Vol. 55, Iss. 5, 2000-05 ,pp. : 679-683

Elsevier

Access to resources Recommend Favorite

Gene therapy for prostate cancer

By Shalev M. Thompson T.C. Kadmon D. Ayala G. Kernen K. Miles B.J.

Urology, Vol. 57, Iss. 1, 2001-01 ,pp. : 8-16

Elsevier

Access to resources Recommend Favorite

Gene therapy targeting kidney diseases: routes and vehicles

By Isaka Yoshitaka

Clinical and Experimental Nephrology, Vol. 10, Iss. 4, 2006-12 ,pp. : 229-235

Springer Publishing Company

Access to resources Recommend Favorite